Plans to establish new partnerships with other international drug regulators could result in the approval of new drugs for use in the UK. The UK regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), will receive 10 million pounds to assist in streamlining the approval process for new medical products, according to Chancellor Jeremy Hunt. […]
Continue Reading
India is experiencing a rapid spread of the H3N2 influenza virus. The country has seen a significant increase in the number of cases of the infection over the past few days. This infection is almost identical to the COVID-19 infection, but their natures are very different. Up until March 9th, 2023, the states reported a […]
Continue Reading
The omicron single-dose booster shot for children under the age of five was approved by Pfizer and its partner BioNTech SE by the US Food and Drug Administration (FDA). According to the agency, children who have already received three doses of the initial vaccine will be eligible for the booster. After receiving the clinical trial […]
Continue Reading
Glenmark Pharma has announced that the US Food and Drug Administration (USFDA) has granted it permission to distribute a generic version of Pfizer’s antibiotic Cleocin capsules. Clindamycin Hydrochloride Capsules with potencies of 75 mg, 150 mg, and 300 mg will be distributed in the United States by Glenmark Pharmaceuticals Inc, an Indian subsidiary. This endorsement […]
Continue Reading
Pharma giant Pfizer announced that a first-of-its-kind fast-acting nasal spray for treating migraines has been approved by the US Food and Drug Administration (FDA). In a statement, Pfizer said that it expects the drug Zavzpret to be in pharmacies in July 2023. Angela Hwang, the chief commercial officer of the pharmaceutical company, said that, the […]
Continue Reading
Acadia Pharmaceuticals, Inc. (ACAD) announced that DAYBUE (trofinetide), a treatment for Rett syndrome, has been approved by the US FDA for use in adults and children over the age of two. The first and only drug that has been approved for the treatment of Rett syndrome is DAYBUE. This day marks a significant turning point […]
Continue Reading
India logged 379 new COVID-19 contaminations, while the dynamic cases rose to 3,177, as per the Association Wellbeing Service information refreshed. India’s Maharashtra state has reported one death out of 5,30,776 reported victims, according to data updated at 8 a.m. The number of COVID-19 cases was 4.46 crore (4,46,89,072). The ministry’s website states that the […]
Continue Reading
Alembic Pharmaceuticals Ltd announced that, Brexpiprazole tablets, which are used to treat schizophrenia and major depressive disorder, have received tentative approval from the United States Food and Drug Administration (FDA). Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg have received […]
Continue Reading
Nelarabine Injection, an oncology drug developed by Shorla Oncology, has received US FDA approval for the treatment of T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma (T-LBL). Nelarabine Injection offers patients a substitute for a product that has historically been scarce. Sharon Cunningham, CEO and co-founder of Shorla Oncology, said that they are very […]
Continue Reading
The most popular insulins manufactured by Eli Lilly will have seen significant price reductions. Eli Lilly, a pharmaceutical company, has announced plans to reduce the price of its Humalog and Humulin insulins by 70%. This price cut was made public after the price of insulin skyrocketed, which was heavily criticized by lawmakers in the United […]
Continue Reading